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Abstract
Quantifying the action of antibiotics on biofilms is essential to devise thera-
pies against chronic infections. Biofilms are bacterial communities attached
to moist surfaces, sheltered from external aggressions by a polymeric matrix.
Coupling a dynamic energy budget based description of cell metabolism to
surrounding concentration fields, we are able to approximate survival curves
measured for different antibiotics. We reproduce numerically stratified dis-
tributions of cell types within the biofilm and introduce ways to incorpo-
rate different resistance mechanisms. Qualitative predictions follow that are
in agreement with experimental observations, such as higher survival rates
of cells close to the substratum when employing antibiotics targeting active
cells or enhanced polymer production when antibiotics are administered. The
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current computational model enables validation and hypothesis testing when
developing therapies.
Keywords: Dynamic energy budget, bacterial biofilm, antibiotic, numerical
simulation.
1. Introduction
Biofilms are bacterial aggregates that grow on moist surfaces, encased in a
self-produced polymeric matrix, see Figure 1. The matrix creates a favorable
environment for their development, facilitating nutrient, oxygen and waste
transport [30]. It also acts as a shield against external aggressions by flows,
disinfectants and antibiotics. The minimal bactericidal concentration (MBC)
and minimal inhibitory concentration (MIC) of antibiotics to bacteria in their
biofilm habitat may be up to 100-1000 fold higher compared with planktonic
bacteria [1, 16].
Implant associated infections typically involve biofilm growth on the sur-
face of the implant [40]. They form on medical equipment and prosthe-
ses, such as pacemakers and endotracheal tubes, central lines, intravenous
catheters, stents and artificial joints. Bloodstream infections, and many
other hospital-acquired infections, may be caused by them. Biofilms may
also spread on body surfaces such as heart valves (endocarditis), teeth, the
lungs of cystic fibrosis patients (pneumonia), the middle ear and nose (oti-
tis, rhinosinusitis), bones (osteomyelitis) or in chronic wounds [16]. The
biofilm matrix hinders phagocytosis and other actions of the inmune system.
Bacteria surviving standard antimicrobial therapies are able to reproduce,
originating chronic infections [38]. To tackle this problem, we must be able
to understand how antibiotics act and how resistance to antibiotics develops.
Antibiotics affect cells in diverse ways [19]. β-lactams (penicillins, cepha-
losporins, carbapenems) and glycopeptides (vancomycin) inhibit cell-wall
synthesis. Aminoglycosides (streptomycin, gentamycin, tobramycin) inhibit
protein synthesis. Quinolones (ciprofloxacin, ofloxacin) inhibit DNA replica-
tion. Tetracyclines inhibit translation. Polymyxins such as colistin disrupt
charge distributions in the outer cell membrane. Eventually, the damage
caused to the cell produces its death. To exert their antibacterial action, an-
tibiotics undergo a certain process. They need to penetrate the cells, remain
stable and accumulate to reach inhibitory concentrations. Sometimes they
have to take an active form. After detecting their target, they interact with
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Figure 1: Schematic representation of a biofilm. The film, formed by bacterial cells
encased in a polymeric matrix (EPS), adheres to a substratum and receives nutrients,
oxygen and antibiotics from the surrounding flow.
it to exert their action. Interferences in either of these processes may result
in cell resistance to the antibiotic. Resistance typically proceeds through
efflux systems (the antibiotic is pumped out of the cell), chemical alterations
of the antibiotic (cellular enzymes degrade it), mutations in antibiotic target
molecules, and non-heritable resistance caused by environmental conditions
[9, 16, 19, 36, 37]. The main resistance mechanisms for different types of
antibiotics are summarized in [19].
The biofilm environment enhances bacterial resistance in a number of
ways. Biofilm development is influenced by quorum sensing [8]. Through
quorum sensing mechanisms, bacteria sense when a critical number of them
are present in the environment. They respond by activating genes that pro-
duce exopolysaccharides [7]. The polysaccharide matrix surrounding the bac-
terial community delays diffusion of antibiotics inside the biofilm. Neverthe-
less, direct measurements suggest that some antibiotics equilibrate within
the biofilm [6] after a waiting time. Pseudomonas aeruginosa tends to be the
main source of gram-negative infections in intensive care units in developed
countries [32]. P. Aeruginosa and other bacteria express β-lactamase, an
enzyme that attacks β-lactams. An enzyme breaking the antibiotic at a rate
at which it crosses the cell membrane combined with delayed diffusion might
explain resistance to penicillins, but not to other antibiotics [6].
As mentioned above, as we penetrate from the outer biofilm surface to-
wards the interface with the substratum, gradients of oxygen and nutrients
develop. Oxygen depletes [5, 42]. These gradients result in increased dou-
bling times for cell division and reduced bacterial metabolic activity. The
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intensity of metabolic processes is stratified: high activity in the outer lay-
ers and slow growth or no growth in the inner core. These dormant cells
are partially responsible for tolerance to antibiotics. Popular monotherapies
with β-lactams are only active against dividing cells [3], forcing combinations
with antibiotics that are active against nondividing cells, such as colistin [16].
Oxygen limitation and metabolic rates are also important factors enhancing
the tolerance of biofilms to ciprofloxacin and aminoglycosides [41].
In the biofilm, bacteria are exposed to oxidative stress, that causes hiper-
mutability. Enhanced production of reactive oxygen species (ROS), either
released in response to the infection or produced by the alterations in the
DNA repair system of the bacteria, leads to an environment with low oxygen
tension filled with oxygen radicals [16, 29]. Augmented β-lactamase syn-
thesis, overexpression of efflux-pumps and increased EPS production follow
[4, 16, 26]. Studies with toxicants have also shown increased EPS produc-
tion and ability to adapt to the toxicant, repairing damage to the cell [13].
Quorum sensing inhibitors [15], efflux inhibitors [27, 28], antioxidants reduc-
ing the oxidative stress and mutations [29], together with enzymes able to
dissolve the biofilm matrix [2], may provide strategies to overcome resistance
mechanisms.
Mathematical modeling can assist in the design of therapies and the in-
terpretation of experimental data. Early models were able to reproduce ele-
mentary qualitative behavior. Reference [35] uses coupled reaction-diffusion
equations for the concentration of oxygen, antibiotics and the volume frac-
tions of live and dead cells to predict survival profiles inside thick biofilms
due to slow growth. Reference [33] predicts that the biofilm matrix can
not prevent diffusion of β-lactam antibiotics into the bacteria provided the
amount of chromosomal β-lactamase is low. The diversity of the mecha-
nisms involved in biofilms resistance to antibiotics suggests the opportunity
of adapting dynamic energy budget (DEB) frameworks to describe the effect
of antibiotics on them. DEB models have already been exploited to describe
the effects of toxicant exposure on populations of floating bacteria [21]. Like
antibiotics, toxicants interfere with the metabolism of cells and increase the
energy required for cell maintenance. The cell requires additional energy
to expel the toxicant and repair damage caused by toxicant activity (DNA,
RNA, protein repair).
Dynamic energy budget models relate biomolecular processes to individ-
ual physiology and population dynamics [23]. They have been successfully
used to study scaling behaviors of all sorts of living beings, from plants and
4
animals to cells [14]. Basic DEB models describe acquisition of biomass and
energy, as well as energy allocation for cell maintenance, growth and divi-
sion. A standard description of aging and death processes is also available
[23]. Surplus reactive oxygen species (ROS) causes irreparable damage to
the cell. Damage components become ‘damage inducing compounds’, result-
ing in cell malfunctioning and further damage, raising the death probability.
Death and damage are represented through ‘hazard’ and ‘aging acceleration’
variables. Antibiotic impact, like toxicant consequences, must be described
modifying standard fluxes and rates. To represent the effect of toxicants
on floating bacteria, Reference [21] included acclimation to the toxicant ef-
fect, environmental degradation due to cell products, toxicant induced ROS
production, and their influence on assimilation, growth, aging and harzard
rates. The only variable states characterizing the environment are substrate
and toxicant concentrations.
In this paper, we analyze antibiotic effects on Pseudomonas aureginosa
biofilms by means of an adapted DEB model. Unlike typical DEB models for
cells [21], we introduce here spatial variations in the concentration equations
to study the local influence of the biofilm shape and composition. Spatial
gradients in the concentrations of oxygen and antibiotics are relevant to the
bacterial survival profile in these communities. We couple numerically the
metabolism of individual cells to the diffusion equations describing concen-
trations and some additional field. Our model accounts for EPS production,
identified as a cause of antibiotic resistance. The antibiotic acts on growth,
maintenance, aging and hazard rate in a similar way to toxicants. EPS pro-
duction increases acclimation, while reducing growth, damage and hazard
rates, see Figure 2.
We have fitted the model for a quantitative agreement with the death
rates reported for P. aureginosa under different antibiotics [17] and explored
the spatial variations in the dead/alive cell distribution. Our simulations
reproduce expected qualitative trends. Augmenting the dose, the number of
dead cells increases. Increasing the EPS extent, the number of dead cells
decreases. Antibiotic presence enhances EPS production. When we apply
antibiotics targeting active cells a necrotic region progressing from the outer
biofilm layers to the inner biofilm core appears. Instead, antibiotics targeting
slowly growing cells would destroy first the inner dormant core.
The paper is organized as follows. Section 2 describes our spatially vary-
ing DEB model. Section 3 presents the computational setting. Parameters
are fitted to measured death rates in Section 4. Section 5 discusses numerical
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Figure 2: The κ rule for partition of energy in biofilm forming bacteria. A fraction
κ of the total energy is devoted to maintenance and growth of the cell. The remaining
1− κ fraction is invested in polymer (EPS) synthesis.
simulations illustrating the above mentioned qualitative behaviors. Finally,
Section 6 states our conclusions.
2. Basic DEB model for a biofilm including EPS production and
antibiotics
In this section we propose the basic equations for a dynamic energy bud-
get theory (DEB) of a biofilm including polymer (EPS) production, coupled
to diffusion of oxygen and antibiotic concentrations. We also introduce equa-
tions describing the effect of the antibiotic on the bacteria. The framework
is similar to that developed in [21] for the study of the effect of toxicants on
a homogeneous population of floating bacteria. Differently, in a biofilm we
must incorporate EPS production, as well as diffusion processes in a num-
ber of spatially varying magnitudes, taking into account the specific action
mechanisms of antibiotics. Also, the population of bacteria differentiates in
several types. Only some of them become EPS producers. The remaining
bacteria grow and divide normally, unless resources are so scarce to trigger
deactivation or damage is large enough to kill them.
2.1. The basic energies
DEB is essentially a scaling theory of different types of energies charac-
terizing the biofilm. The basic differential equations describe the fluxes of
these energies. We apply a variant of the κ rule [23], see Figure 2. A κ
fraction of the energy is used for bacterial growth and division. Notice that
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bacteria do not mature and age, just grow and divide. A 1 − κ fraction of
the energy is used for EPS production.
Each alive bacterium in the biofilm evolves according to the following
system of equations, setting κ = 1 for normal cells and 0 < κ < 1 for EPS
producers.
1. Scaled energy density e(t):
de
dt
= ν ′(f − e), f = Co
Co +Ko
, ν ′ = νAν, (1)
where Co is the oxygen limiting concentration, Ko the limiting con-
centration half saturation value, f is the scaled functional response, ν
is the energy conductance and ν ′ takes into account toxic effects on
conductance through νA, defined in equation (7).
2. Dimensionless cell volume v(t):
dv
dt
= (r
a
aM
− h)v, r =
(
ν ′e−mκgκ
e+ gκ
)+
, (2)
where r is the bacterial (cell biomass) production rate, mκ is the main-
tenance rate and gκ is the investment ratio. The remaining parameters
and magnitudes are linked to environmental toxicity, in our case antibi-
otic concentration, see below. h is the hazard rate, a is the acclimation
energy density and aM is the target acclimation energy. The symbol
+
stands for positive part, which becomes zero for negative expressions.
Bacteria are rod-shaped, and grow in length. If we fix an average
radius, equation (2) provides an equation for the time evolution of the
cell length l.
3. Dimensionless volume of EPS ve(t):
dve
dt
=
gκ
ge,κ
(r
a
aM
− h)v + mκ
ge,κ
v = rev. (3)
This equation defines a rate of EPS production re. In absence of accli-
mation and hazard effects (a = aM , h = 0), we set the reference rate
re = kr+k
′, that can be fitted to experiments, as we explain in Section
5.
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The dimensionless magnitudes e, v and ve represent the fundamental energies
characterizing the cell (bacterium) and its EPS production. Their fluxes are
written here for each individual cell, e being the total energy available for
both growth and reproduction and for EPS production. v keeps track of the
volume of the cell as it grows, this is the energy available for reproduction
by division. ve keeps track of the energy available to form the matrix that
constitutes the biofilm and protects the bacterium. They may be related to
dimensional volumes V and Ve multiplying by a characteristic cell volume
Vm. The dynamics of these variables is coupled to the evolution of other
magnitudes, governed by equations we introduce next. Table 1 collects all
the variables appearing in the model. Table 2 gathers the parameters, spec-
ifying units and selected values. The discussion in Section 4 suggests that
a characteristic time scale for equations (1)-(3) is set by the bacterial dou-
bling time ∼ 1
µmax
or the conductance ν, in a time scale of hours. Diffusion
processes for oxygen and antibiotic concentrations, however, evolve in a time
scale of seconds, as concluded from the equations presented next and the
parameter values in Table 2.
2.2. Diffusion of oxygen and antibiotics
Let Co(x, t) denote the concentration of oxygen and Ca(x, t) the con-
centration of antibiotic. These quantities are described by two diffusion
equations. The antibiotic accumulated inside the cell is described using the
antibiotic cellular density [CIN ](t), as discussed next.
1. Oxygen concentration diffusion inside the biofilm:
∂Co
∂t
= do∆Co − µmaxf
Yx/o
X − (kµmaxf + k
′)
Yp/o
X, (4)
where µmax is the maximum specific growth rate. k is the growth as-
sociated polymer formation rate coefficient and k′ is the non-growth
associated polymer formation rate coefficient. Yx/o is the cellular yield
coefficient of Co and Yp/o is the polymer yield coefficient of Co. do is the
oxygen diffusion coefficient inside the biofilm. X is the cellular struc-
ture concentration computed in a control volume VT containing N cells:
X = ρx
∑N
i=1 Vi/VT , ρx being the density of a cell. When the volume
control contains just one cell, we set X = ρxv, where v is the dimen-
sionless cell volume. Equation (4) is supplemented with the boundary
condition Co = Co,out at the interface with the oxygen providing fluid
and the no-flux condition ∂Co
∂n
= 0 at the biofilm/substratum interface.
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Symbol Units Variable
t s time
x m space
Symbol Units State variable Equation
e n.d. Scaled energy density Eq. (1)
v n.d. Dimensionless bacterial volume Eq. (2)
l n.d. Dimensionless bacterial length Eq. (2)
ve n.d. Dimensionless EPS volume Eq. (3)
ε n.d. Environmental degradation Eq. (8)
a n.d. Acclimation energy density Eq. (9)
h hr−1 Hazard rate Eq. (10)
q hr−2 Aging acceleration Eq. (11)
Co
mg
`
Oxygen concentration Eq. (4)
Ca
mg
`
Antibiotic concentration Eq. (5)
[CIN ]
mg
Cmol
Antibiotic cellular density Eq. (6)
Symbol Units Auxiliary variable Equation
f n.d. Scaled functional response Eq. (1)
r hr−1 Bacterial production rate Eq. (2)
ν ′ hr−1 Conductance modified by exposure Eq. (7)
Table 1: Variables of the model. The state variables define the model. The auxiliary
variables are introduced for simplicity. Non-dimensional variables are labeled ’n.d.’.
2. Antibiotic concentration diffusion inside the biofilm:
∂Ca
∂t
= da∆Ca − (Re +R)Ca, (5)
where Re and R are evaluated averaging r and re in the control vol-
umen VT . da is the antibiotic diffusion coefficient. Equation (5) is
supplemented with boundary condition Ca = Ca,out at the interface
with the antibiotic providing fluid and the no-flux condition ∂Ca
∂n
= 0
at the biofilm/substratum interface.
3. Antibiotic cellular density:
d[CIN ]
dt
= kIACa − kOA [CIN ], (6)
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where kIA is the antibiotic influx coefficient, and k
O
A is the antibiotic
efflux coefficient. Ca should be the antibiotic concentration outside the
cell, that we take equal to Ca given by (5) in the control volume that
contains the cell. We may set [CIN(0)] = 0 initially.
In view of the parameter values in Table 2, the chemical concentrations
Co and Ca will evolve much faster than the other magnitudes related to cell
behavior, that is, in a time scale of seconds, not hours.
We have to complete the above equations by describing how the antibiotic
and oxygen concentration act on the cell and influence its energy fluxes. We
mostly follow [22, 21] considering the antibiotic to be a toxicant. Besides,
we introduce several new DEB variables and make small modifications to
account for spatial variations.
2.3. The effect on cells of oxygen and antibiotics
The previous equations take into account the decline in the organism’s
capacity to acquire and use energy due to respiration and to the presence of
antibiotics through a diminished conductance, reduced growth due to accli-
mation to the antibiotic and the hazard rate, see Figure 3.
1. Conductance modified by exposure ν ′:
ν ′ = νAν, νA = e−γεε
(
1 +
Ca
KV
)−1
, (7)
where KV is the noncompetitive inhibition coefficient and γε is the
environmental degradation effect coefficient.
2. Environmental degradation ε(x, t):
∂ε
∂t
= dε∆ε+ νε(R + νmmκ)X. (8)
νε is the environmental degradation coefficient and νm is the mainte-
nance respiratory coefficient. X is the cellular structure concentration
computed in the control volume VT containing N cells. R is similarly
computed averaging r over this control volume. The diffusive term ac-
counts for the fact that ε feels the spatial variations. We impose no-flux
boundary conditions.
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Figure 3: Outline of the model. Diagram summarizing the main variables and their
interactions.
3. Acclimation energy density a(t):
da
dt
= (r + re)
(
1− a
aM
)+
, (9)
where aM is the target acclimation energy and
+ stands for the positive
part.
4. Hazard rate h(t):
dh
dt
= q − (r + re)h. (10)
5. Aging acceleration q(t):
dq
dt
= e(sqX q + ha)(ν
′ − r) +
(
dq
dt
)
A
− rq, (11)
where ha is the Weibull aging acceleration and sq is a multiplicative
stress coefficient.
11
6. Aging in acclimation due to dissolved antibiotic and EPS:(
dq
dt
)
A
= kIqA[CIN ]− req, (12)
where kIqA is the dissolved antibiotic toxicity.
Figure 4: The rules of cell division and differentiation. Bacterial cells act in different
ways according to their energy, size and aging rate.
2.4. Cell division, differentiation and death
Bacteria of the Pseudomonas Aeruginosa genus are rod-like. Their volume
is defined by V = piρ2L, ρ being the radius and L the length. Increase in
volume is equivalent to increase in length, setting ρ equal to their average
radius. Reference [34] reports cell lengths L between 1.67 µm and 2.75 µm
for P. Aeruginosa. Diameters 2ρ vary between 0.5-0.73 µm without clear
relation to the length and with a preference for 2ρ = 0.6 µm. Notice that
the equation for length is formally the same as the equation for volume (2),
up to a factor. We may use Vm = piρ
2Lm, Lm being the maximum length, to
nondimensionalize.
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In dimensionless variables, cell division happens provided a threshold
maintenance energy ed is surpassed when a threshold length ld is reached,
see Figure 4. Then the cell divides and creates daughter cells.
Nondividing cells behave in different ways according to their lengths,
energies, aging and hazard rates, see Figure 4:
• For intermediate energies eeps1 ≤ e ≤ eeps2 the cells produce EPS ac-
cording to equation (3), provided they are not newly born. A way to
keep track of their age is the aging rate q, governed by (11). It is set
initially equal to zero for newborn cells. We require q ≥ qeps for the
cell to have the ability to become a EPS producer.
• For low energies e ≤ eeps1, the cell just maintains itself.
• The hazard rate, given by (10), determines when cells die. Their sur-
vival probability p(t) is governed by the equation
dp
dt
= −hp, p(0) = 1. (13)
Now with the energies e, v, ve, oxygen and antibiotic concentrations Co,Ca,
[CIN ] and the variables , a, h, q, which measure how such concentrations
influence the energies, we have a complete set of variables and of equations.
These additional rules define the behavior of each cell.
3. Computational framework
For computational purposes, the biofilm is identified with a slab contain-
ing cells. We divide the slab in a grid of cubic control volumes, that we use to
discretize the concentration fields evaluating their spatial changes. A control
volume VT may contain several cells, or just one, see Figure 5.
Variables e, v, ve, [CIN ], a, h, q, p are assigned to each cell, governed
by equations (1), (2), (3), (6), (9), (10), (11) and (13). These equations use
background values of concentrations and environmental degradation, that are
continuous fields defined on the biofilm, governed by the diffusion problems
(4), (5) and (8).
The computational strategy is the following:
• For a fixed biofilm configuration, we let the diffusion problems for Co,
Ca and ε relax to stationary values, which occurs in a short time scale τ
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Figure 5: Schematic description of the computational arrangement. Continuous
equations for concentrations are discretized in the square grid representing the biofilm.
Each tile contains cells of certain volume and energy, with an associated EPS volume
around it, whose dynamics is governed by the DEB equations. Here, we assume that
each tile contains just one cell. In practice, all these items are stuck together in a more
amorphous mass. This is a simple computational idealization allowing us to combine
macroscopic and microscopic information.
(seconds). These variables are then defined and fixed in all the control
volumes.
• For each cell in the biofilm, we update the values of the variables e,
v, ve, [CIN ], a, h, q, p solving equations (1), (2), (3), (6), (9), (10),
(11) and (13) in a slower time scale T (minutes) using the background
values of Co, Ca and ε.
• We revise the status of all cells in the biofilm, in a random ordering.
Cells differentiate and divide according to the rules stated in Section
2.4. To decide whether a cell dies, we generate a random number
n ∈ (0, 1) and kill the cell if p < nNa
N
, where N is the total number of
cells and Na the current number of alive cells.
• We update the concentration fields and repeat the procedure.
Allocating newborn cells, reabsorbing dead cells and allocating produced
EPS in a 2D or 3D biofilm geometry are challenging issues for which many
14
Figure 6: Schematic description of the computational arrangement. Continuous
equations for concentrations are discretized in the square grid representing the biofilm.
Each tile contains cells of certain volume and energy, with an associated EPS volume
around it, whose dynamics is governed by the DEB equations. Here, we assume that
each tile contains just one cell. In practice, all these items are stuck together in a more
amorphous mass. This is a computational idealization allowing us to combine macroscopic
and microscopic information.
ideas have been proposed depending on the biofilm types [10, 11, 12, 24,
25, 39]. We do not intend to address these issues here. Instead, we work
in a simplified geometry, implementing simple rules that allow us to check
the performance of the DEB dynamics in a spatially varying film. In the
numerical simulations presented here we make the following assumptions:
• The biofilm is a 2D region, divided in cubic tiles for computational
purposes.
• Each tile contains one cell together with EPS and dissolved substances.
The idea is schematically represented in Figure 5.
• When a cell divides, the length and energy split in two. The daughter
cell shifts other cells in the direction of minimal mechanical resistance
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(closest to the surface or to a dead cell).
• When a cell dies, it is reabsorbed by its neighbors, provided there are
enough neighbors alive. A neighbor or newborn cell occupies its place
in that case. Otherwise, its stays there and we get a necrotic region.
• A fraction α ∈ (0, 1) of the EPS produced by equation (3) remains at-
tached to the cell. The rest diffuses through the whole biofilm. There-
fore, when updating the concentrations Ca, Co, ε, we need to update
the diffused concentration of EPS Ce(x, t) too:
∂Ce
∂t
= de∆Ce + (1− α)ReX, (14)
with zero flux boundary conditions ∂Ce
∂n
= 0 on the biofilm boundary.
The equations in Sections 2.2-2.3 set α = 1. All the EPS produced by
a cell remains attached to it. When α 6= 1, Re is replaced by αRe +R′e
in all these equations. αRe represents the fraction of EPS produced at
each site that remains in it. It may be zero when there are no EPS pro-
ducers in that tile. R′e represents the fraction of EPS accumulated due
to global diffusion processes governed by (14). It will always be non zero
by diffusion. The way we evaluate R′e is the following. If at a certain
control volume we start with an initial concentration Ce(t1) to reach a
final concentration Ce(t2) this defines a rate R
′
e =
1
t2−t1 ln(
Ce(t2)
Ce(t1)
). The
overall computational chart is represented in Figure 6.
The physical justification for this treatment of EPS is that the EPS ma-
trix is formed by polymers. Monomers will diffuse easily, but a fraction of
them will form polymeric chains of increasing size attached to the cells. An
empirical justification is that if the produced EPS remains attached to pro-
ducers, the active cells not producing EPS in outer layers die too fast and
form unphysical necrotic layers in absence of any toxicants. In practice, the
EPS matrix envelops and shelters all the biofilm cells.
4. Parameter calibration
Table 2 lists the parameters used in the simulations. The diffusion coef-
ficient for oxygen do is selected so that oxygen penetration inside the biofilm
ranges in the values reported (about 50 µm) [42]. Oxygen penetration depth
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Symbol Units Name Value Source
ρx
mg
`
cell density 47000 [35]
µm biofilm size 1000× 200 chosen
L µm cell length 1.67− 2.75 [34]
2ρ µm cell diameter 0.5− 0.73 [34]
Co,out
mg
`
Oxygen concentration 0.035 [35]
Ko
mg
`
Oxygen half saturation 0.1 [35]
do
µm2
s
Oxygen diffusion 2.2× 104 [42]
µmax hr
−1 Growth rate with oxygen 0.3 [35]
Yx/o
mg cell
mg oxygen
cell yield 0.24 [35]
k mgpolymer
mg cell
growth associated yield 2.2371 estimated
k′ mgpolymer
mg cell hour
non growth associated yield 0.29 estimated
Yx/o
mg cell
mg oxygen
cell yield 0.34 estimated
Yp/o
mgpolymer
mg oxygen
polymer yield 0.56 estimated
Ca,out
mg
`
Antibiotic concentration 0.78, 0.20, 3.13, 1.56 [17]
da
µm2
s
Antibiotic diffusion 0.5× 104 [35]
de
µm2
s
EPS diffusion 104 estimated
dε
µm2
s
Degradation diffusion 0.5× 104 estimated
ν hr−1 Energy conductance 0.84768 [21]
mκ hr
−1 Maintenance rate 0.1266 estimated
gκ n.d. Investment ratio 0.9766 estimated
sq
`
mg
Multiplicative stress coeff. 0.8921× 10−5 estimated
ha hr
−2 Weibull aging acceleration 1.4192× 10−4 estimated
h0 hr
−1 Initial hazard rate 0.4 estimated
kIqA
Cmol
mg hour3
Dissolved antibiotic toxicity s
Ca,out
kOA
kIA
estimated
kIA
`
hrCmol
Antibiotic influx coeff. 8.6× 10−6 [21]
kOA hr
−1 Antibiotic efflux coeff. 0.17251 [21]
KV
mg
`
Noncompetitive inhibition coeff. 154.82 [21]
aM n.d. Target acclimation energy 1.6703 [21]
νε
`
mg
Environmental degradation coeff. 0.23566/12000 [21]
νm n.d. Maintenance respiratory coefficient 0.054703 [21]
γε n.d. Environmental degradation effect coeff. 1 [21]
Table 2: Parameter values used in the simulations. Recall that 1Cmol = 12g.
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is defined as the distance into the biofilm at which the first derivative of
the oxygen concentration reaches 5% of its maximum value. As said before,
oxygen is considered to be the limiting factor [16] for biofilm development
in medical environments. We lack measurements of k, k′, Yx/o and Yp/o in
this case, but we may propose values for Yx/o and Yp/o, k and k
′ based on an
educated guess respecting the proportions observed for carbon [34].
Values for the maintenance rates mκ and investment ratios gκ are inferred
as follows. The macroscopic equations for EPS and cell production are [34]:
dXe
dt
= [kµmaxf + k
′]X,
dX
dt
= µmaxfX.
In absence of acclimation, toxicity and harzard corrections, that is a = aM ,
ν ′ = ν, h = 0, equations (2) and (3) read
dve
dt
=
(
gκ
ge,κ
r +
mκ
ge,κ
)
v,
dv
dt
= rv, r =
(
νe−mκgκ
e+ gκ
)+
.
Notice that the energy governed by (1) tends to an equilibrium e = f for each
cell. We set f = fmax =
Co,out
Co,out+Ko
and e = fmax. Dimensions can be restored
in these equations by scaling v and ve. Comparing with the equations for
Xe and X, we approximate
gκ
mκ
by k
k′ and
νfmax−mκgκ
fmax+gκ
by µmaxfmax. Taking
mκ =
k′
k
gκ, gκ is a positive solution of a second order equation, given by
gκ =
1
2
(
− k
k′
µmaxfmax +
√( k
k′
µmaxfmax
)2 − 4 k
k′
(µmaxfmax − ν)fmax
)
.
The values of the multiplicative stress coefficient sq, Weibull aging accel-
eration ha, dissolved antibiotic toxicity k
I
q,A, influx and efflux coefficients
kIA, k
O
A , and the initial hazard rate h0 in equations (10), (11), (12) and
(13) are fitted to data in reference [17]. To do so, we consider a single
cell of volume v, energy e with density ρx and write down the equations
for the hazard rate h, aging acceleration q and survival probability p set-
ting [CIN ] = Ca,out
kIA
kOA
, the equilibrium value. Taking a = h0, b = r + re,
c = e ha(ν
′ − r), d = e sq ρxv(ν ′ − r) and s = kIqA[CIN ], the solutions are:
q(t) =
c+ s
d− b
(
e(d−b)t − 1) ,
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h(t) =
(
a− c+ s
d− b
(
1
d
− 1
b
))
e−b t +
c+ s
d− b
(
e(d−b)t
d
− 1
b
)
,
p(t) = exp
(
a
b
(
e−b t − 1)− c+ s
d− b
(( 1
b d
− 1
b2
)
e−b t +
e(d−b)t
d(d− b) −
1
b
t− 1
b d
+
1
b2
− 1
d(d− b)
))
. (15)
The way we find values for a, b, c, d, s is the following. We first remove the
antibiotic and seek to adjust the viable cell counts in Table 1 of reference [17]
for the control population. Figure 7 compares the bacterial counts at times
3, 6, 24 hours with our fittings of log10(pN) for a population of the initial
size N = 105.75 CFU/m. Once these parameters are fitted, we successfully fit
the remaining parameters to the approximate number of viable cells for four
different antibiotics: levofloxacin, ciprofloxacin, gentamicin, ceftazidime.
We approximate the data in Table 1 of [17] in absence of antibiotics
dividing by 10 the values sq and ha from reference [21]. We choose average
values for e and v, v = 0.5, e = median(f(Co,out)) ≈ 0.003, and set ν ′ = ν.
Then, c = e ha(ν
′ − r) ≈ 3.61× 10−7 y d = e sq ρxv(ν ′ − r) ≈ 4.8× 10−3. We
vary a and b so as to approximate the data in Table 1 of [17]: a = h0 = 0.4
and b = 0.29. These values are chosen because the fit still holds when we
replace single cells by a biofilm formed by a few hundred layers. Since r ∼ 0
for EPS cells, we set k′ = b and keep the ratio k
k′ observed for carbon.
5. Numerical results
The purpose of this section is to investigate the influence of the spatial
variations of the concentrations in cell death. To simplify, in the small scale
2D simulations presented here we consider tiles of size 1µm×1µm in Figure
5. Figure 8 shows the spatial structure of the oxygen distribution in a biofilm
of maximum width 1000µm and maximum height 200µm. We solve equation
(4) discretized in the grid, with Dirichlet boundary condition Co = Co,out on
the interface with air and Neumann boundary condition dCo
dn
= 0 on the
bottom interface. We take f(Co) =
Co
Co+Ko
and X = ρxv, where v is the
dimensionless volume of the cell contained in the tile. Figure 8 sets v = 0.5.
Initially, Co = 0 inside the biofilm. We solve using a explicit scheme until Co
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Figure 7: Comparison of theoretical predictions and experimental data. The
predictions provided by formula (15) for p are compared to the data in Table 1 of Reference
[17]. The parameter values for p(t) are a = 0.4, b = 0.29, c = 3.61 × 10−7 and d =
4.8 × 10−3. The additional parameter s is adjusted for each antibiotic. Circles represent
log10(p ·N) with N = 105.75 (magenta) and N = 105.75±0.10 (red). Asterisks represent the
measurements in Table 1 of Reference [17] for the same antibiotic doses. As before, light
(blue) colors correspond to the mean measured value, whereas dark (black) colors mark
the error interval.
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Figure 8: Equilibrium oxygen concentration in dimensionless units CoKo .
Figure 9: Equilibrium energy distribution
relaxes to a stationary configuration:
C`+1o;i,j = C
`
o;i,j+δt do
C`o;i,j+1 + C
`
o;i+1,j − 4C`o;i,j + C`o;i,j−1 + C`o;i−1,j
δx2
+δt g(Xi,j),
where g(X) represents the source in equation (4). The spatial step δx is the
side of a tile. Tiles in the spatial grid are labelled using a couple of indices
(i, j) to indicate their position. Time is discretized with time step δt, so that
t`+1 = t` + δt = (`+ 1)δt and C
`
o;i,j ∼ Co;i,j(t`). For this scheme to be stable,
we need δt do
δx2
≤ 0.5. We advance in a time scale of seconds. Similar schemes
are used to update the additional space dependent concentrations Ca, Cε, Ce
when needed.
The cell energies are governed by DEB equations depending on f =
Co
Co+Ko
, which varies through the biofilm. Figure 9 represents the equilibrium
distribution e = f(Co) at each tile. The maximum energy is em =
Co,out
Co,out+Ko
.
In view of the energy distribution, we set threshold values eeps1 = 7× 10−6,
eeps2 = 0.02 and ed = 0.01 to produce EPS or divide.
Starting from a uniform distribution of cell types (non EPS producers,
ve = 0) with volumes v(0) = 0.5 we compute the evolution of their energy
and size to check the evolution of the cell type distribution with time. We
choose as initial energy a perturbation of the equilibrium energy distribution
at each location, and fix q > qeps = 10
−8. By solving the equations for e,
v, ve for each cell tile ignoring aging and hazard, we see that cells evolve to
be EPS producers in an intermediate region. The outer layers are normal
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(a)
(b)
Figure 10: Equilibrium distribution of cell types: (a) for the equilibrium energy
e = f(Co), (b) for larger energy e = 10f(Co). Light green represents active cells. Dark
green represents dormant cells. Green represents EPS producers.
active cells, likely to divide. A thin inner core may be formed by cells with
little energy than do not divide and do not produce EPS. The equilibrium
distribution of types is depicted in Figure 10(a). If we increase the initial
energy, we may find intermediate states such those in Figure 10(b), where
that thin inner layer vanishes. Repeating the simulation with initial volumes
v randomly distributed between (0.45, 0.6) and random perturbations of the
equilibrium energy we find similar results with a smoother transition between
regions, reflecting the noise.
To study the distribution and number of dead cells, as well as the effect of
antibiotics, we activate the equations for aging and hazard rates. We compute
a reference concentration of antibiotic Ca in the biofilm solving (5) with
Dirichlet boundary condition Ca = Ca,out on the interface biofilm/air and
Neumann boundary condition dCa
dn
= 0 on the bottom interface. We assume
that all cells are undifferentiated in this reference computation (Re = 0) and
employ the equilibrium oxygen and energy distributions to evaluate R. The
concentration of antibiotics inside the biofilm evolved towards a constant, and
we will take it to be approximately constant and equal to Ca,out in the biofilm.
Figure 11 shows that the fittings of the time evolution of the survival rates
performed in Section 3 persist when all the biofilm is taken into account. A
low energy cell population is considered in that figure, forbidding cell division
for simplification.
The model yields information on qualitative behavior that agrees with
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Figure 11: Simulated live cell counts compared to experimental measurements in
Table 1 of Reference [17]: (a) in absence of antibiotics, (b) for ceftazidime. The continuous
curve represents the simulated values. Asterisks depict the measurements in Table 1 of
reference [17] for the same antibiotic doses, black lines represent the error bars.
some experimentally observed tendencies and may be useful to understand
the causes or to predict new behaviors. Panels (a) and (c) in Figure 12 re-
veal that for an antibiotic acting mostly on active cells like Ceftazidime (it
inhibits cell wall synthesis), cells mostly die in the outer biofilm layer and
the extent of the dead region increases with the dose of antibiotic. Panel (b)
shows that it also increases with time. We are assuming that the antibiotic
has diffused inside the biofilm so that the spatial distribution of dead regions
depends on what type of cells are preferential targets of the antibiotic under
study. For antibiotics like Ceftazidime, acting on active cells, we use tox-
icity coefficients depending on the cell activity, of the form e
0.1median(e)
kIqA.
For other antibiotic like colistin, targeting the dormant core cells, we may
use toxicity coefficients decreasing with the cell activity instead. Mutations
increasing the efflux might be accounted for raising the value of that coeffi-
cient. Augmented resistance to deactivating enzymes may be incorporated
modifying the toxicity.
In absence of antibiotics cells die in the inner regions in a scattered way.
Active cells in the outer layers are still more likely to die, a standard fact
in the DEB theory, that assumes organisms with more energy more likely to
suffer damage. That effect would be diminished increasing the difussivity of
produced EPS de, or allowing differentiation into EPS producers for larger
energies. Cells that die in the outer layers in absence of antibiotics may also
be eroded by external agents or absorbed by newly born cells. Unlike the
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(a)
(b)
(c)
Figure 12: Distribution of cell types applying Ceftazidime. (a) for the reference
dose Ca = 3.13
µg
m` after 90 minutes, (b) same dose, after 180 minutes, (c) a dose 100
fold larger, after 90 minutes. Dead and active cells are depicted in red and green colors,
whereas EPS producers are dark green. The number of dead cells increase with time and
the doses. The initial energy is e(0) = 10f(Co).
previous case, we do not get an expanding outer necrotic region. Analyzing
the amount of EPS produced with and without antibiotics, we find that the
presence of antibiotics enhances EPS production, see Figure 13. This fact is
also responsible for the small difference between panels (a) and (c) of Figure
12. The number of dead cells is larger for panel (c), but not as large as could
be expected from the dose increase due to enhanced EPS production that
neutralizes that fact.
6. Conclusions
Coupling dynamic energy budget dynamics for the metabolism of indi-
vidual cells to diffusion equations for the evolution of chemical fields we have
reproduced qualitative trends experimentally observed in bacterial biofilms
under the action of antibiotics. We calibrate the parameters for a quan-
titative agreement with the death rates measured for P. aureginosa under
a number of antibiotics and study spatial variations in the distribution of
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(a)
(b)
Figure 13: Difference Ce − C(1)e of EPS concentrations when antibiotics are ad-
ministered. C
(1)
e represents the concentration when Ca,out = 3.13
µg
m` . (a) Ce − C(1)e , Ce
computed for Ca,out = 6.26
µg
m` . (b) Ce − C(1)e , Ce computed for Ca,out = 18.78 µgm` . The
initial energy is e(0) = 10f(Co) and the difference is represented after one hour in both
cases. The mean value of the differences is positive.
dead and alive cells. Our numerical simulations show that the presence of
antibiotics enhances production of polymeric matrix, as expected from true
measurements. For antibiotics targeting active cells, we observe the forma-
tion of a necrotic outer layer, that expands deeper in the biofilm as time
goes on and the antibiotic dose increases. Our tests suggest ways to handle
antibiotics targeting dormant cells and resistance mechanisms such as efflux
pumps or enzymes. New experimental measurements [31] would be required
to calibrate the mechanisms to practical cases. The current computational
model enables validation and hypothesis testing when developing therapies
to handle chronic infections caused by biofilms. Determining the true rele-
vance of increasing the dose and whether periodic or continuous infusion of
antibiotics is more effective [20] would be essential for practical applications.
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